Disruption of RNA Splicing Increases Vulnerability of Cells to DNA-PK Inhibitors
Anastasia P. Kovina, Artem V. Luzhin, Victor V. Tatarskiy, Dmitry A. Deriglazov, Natalia V. Petrova, Nadezhda V. Petrova, Liya G. Kondratyeva, Omar L. Kantidze, Sergey V. Razin, Artem K. Velichko · 2024
Read Disruption of RNA Splicing Increases Vulnerability of Cells to DNA-PK Inhibitors by Anastasia P. Kovina, Artem V. Luzhin, Victor V. Tatarskiy, Dmitry A. Deriglazov, Natalia V. Petrova, Nadezhda V. Petrova, Liya G. Kondratyeva, Omar L. Kantidze, Sergey V. Razin, Artem K. Velichko (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11546466.txt.
Description
Anastasia Kovina and co-authors hunt for genes that make cells fragile to a cancer drug class in a 2024 study. The drugs block DNA-PK, a kinase that patches double-strand breaks in DNA and runs high in many tumors.
Using a CRISPR screen, the team knocked out genes one by one and asked which losses left cells hypersensitive to the blockers. Over one hundred genes turned up, clustered in DNA copying, cell cycle control, and RNA processing. The title finding stands out: breaking the RNA splicing machinery makes cells markedly weaker against DNA-PK inhibition. The gene list doubles as a set of candidate markers for predicting which patients might answer this therapy best.
Catalog record
| CREATOR | Anastasia P. Kovina, Artem V. Luzhin, Victor V. Tatarskiy, Dmitry A. Deriglazov, Natalia V. Petrova, Nadezhda V. Petrova, Liya G. Kondratyeva, Omar L. Kantidze, Sergey V. Razin, Artem K. Velichko |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 34 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |